Yosuke Okada

Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation

Aldemar Montero, Yosuke Okada, Masato Tomita et al. · Journal of Clinical Investigation · 2000 · 470 citations · Full text

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus

Keiichi Torimoto, Yosuke Okada, Hiroko Mori et al. · Cardiovascular Diabetology · 2013 · 272 citations · Full text

Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture

Yosuke Okada, Joseph A. Lorenzo, Amanda Freeman et al. · Journal of Clinical Investigation · 2000 · 196 citations · Full text

Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK

Takahisa Tanikawa, Yosuke Okada, Rena Tanikawa et al. · Journal of Vascular Research · 2009 · 194 citations